{
  "trial_id": "NCT04236843",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Rome IV criteria for IBS diagnosis",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Investigation to exclude other gastrointestinal organic cause(s)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Moderate-to-severe IBS symptoms (IBS-SSS score \u2265175)",
      "label": "not_met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Pregnant or lactating women",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Use of antibiotics or probiotics within 1 month prior to FMT",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Immunocompromised patients (immune-suppressive medications)",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "notes": "The patient has atypical hemolytic uremic syndrome, which may be a comorbidity. He is not pregnant or lactating and does not have a history of antibiotic use within the past month.",
  "_meta": {
    "topic_id": "68",
    "trial_id": "NCT04236843",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}